Kura Oncology (KURA) Current Leases (2019 - 2026)

Kura Oncology (KURA) has 8 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.

• Current Leases for Q1 2026 came in at $1.3 million, down 32.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 32.65% YoY), and the FY2025 annual result was $1.3 million, down 32.11% from the prior year.
• Current Leases was little changed at $1.3 million in Q1 2026 per KURA's latest filing, from $1.3 million in the prior quarter.
• Over five years, Current Leases peaked at $2.3 million in Q2 2023 and troughed at $1.3 million in Q4 2025.
• A 5-year average of $1.8 million and a median of $1.7 million in 2025 frame the typical range for Current Leases.
• The sharpest annual moves came in 2024 and 2025: Current Leases sank 41.55% in 2024, then jumped 39.77% in 2025.
• A 5-year view of Current Leases shows it stood at $2.3 million in 2022, then tumbled by 35.03% to $1.5 million in 2023, then climbed by 24.9% to $1.9 million in 2024, then sank by 32.11% to $1.3 million in 2025, then climbed by 0.47% to $1.3 million in 2026.
• Business Quant data shows KURA's Current Leases at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.